Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Common Stock · CUSIP: 59045L106

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLC

    Shares: 11,578,447.00 · Class: 9.99%

  • Oleg Nodelman

    Shares: 11,578,447.00 · Class: 9.99%

  • EcoR1 Capital Fund Qualified, L.P.

    Shares: 10,918,474.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000773
Form type
SCHEDULE 13G/A
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Dec 23, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub